IV Pharmacological Approaches to Treating Migraine & Pain in the Clinic

Size: px
Start display at page:

Download "IV Pharmacological Approaches to Treating Migraine & Pain in the Clinic"

Transcription

1 IV Pharmacological Approaches to Treating Migraine & Pain in the Clinic John Claude Krusz, PhD, MD Medical Director Anodyne Headache and Pain Care, Dallas & Grapevine, Texas PAIN44

2 Channels Ions (carriers of current) Na +, Ca ++, Mg ++, K + Na+ : NAP, multiple forms (cloned) Ca++ : good guy; excitotoxic in excess Mg++ : physiologic antagonist to Ca++, blocks Ca++ entry at NMDA glutamate receptor K+: repolarization, can block glutamate release

3 Neurotransmitters Good guys: 5HT, NE Enkephalins, endorphins Ketamine [NMDA receptor blockade] Mg ++

4 STRATEGIES INPATIENT Cost, time, inconvenien ce DHE45 protocol often a mainstay [after 25 years!!] Ins co won t pay often sleep quality is ignored OUTPATIENT more convenient much cheaper than average cost of ED visit! (over $4000) in our hands a much higher success rate On demand, with the right attitude

5 OUR STORY FOR OUTPATIENT TREATMENT success defined as >50% reduction in level of headache/pain severity with treatment [ie, a #8/10 reduced to #3/10 or less] 62/1874 refractory headaches/migraines were successfully treated in the clinic 96% success rate 34 of 62 retreated in clinic 14 of 22 went to ED 14/62 elected not to retreat

6 Acute Treatment is not about Medication ITS ABOUT OUTCOME AND PRODUCTIVITY

7 Acute IV Interventions in the Clinic All IV (often with pulse oximetry monitoring) dihydroergotamine (DHE-45) mg usually with metoclopromide (Reglan) 10 mg q 1-2 hrs MgSO4-1 to 2 gm in NS w/ or w/o dexamethasone (Decadron) 4-6 mg or ketorolac 30-60mg over 1 hour valproate sodium (Depacon) mg over 5 to 10 minutes; can repeat dose methocarbamol (Robaxin) mg over 1-2 hours other antinauseants: metochlopramide droperidol mg q15 min; ondansetron IV 2-4mg prn

8 More Exotic All IV lidocaine (needs pulse oximetry) propofol (needs pulse oximetry) ketamine (needs pulse oximetry) IV tramadol not available in US IV levetiracetam IV baclofen (not available in US)

9 MgSO 4 Antagonist for calcium (bad guy in excess) Therefore, blocks glutamate (bad guy)- that s a good thing!! Fairly inexpensive recent shortage Few side effects Can turn down flare-ups of pain, headache and muscle spasm

10 Dexamethasone Steroid anti-inflammatory agent (potent and clean) can be used orally as well for short course Often used with MgSO 4 or many other agents

11 DHE-45 Can be used IV or IM First published in 1987 High success rates Pre-medicate with antinauseant Affects multiple receptor types Available in Nasal Spray form [Migranal NS ] Recent success in pre-empting perimenstrual and early AM migraines * *Krusz, JC, Cammarata, D, Scott, V, AJPM, 16:78-83, 2006

12 Valproate sodium rapid dosing IV mg over 45 min can reduce/eliminate refractory migraines in clinic great treatment for status migrainosus More than 72 hrs of unremitting migraine Recent data with this submitted for publication* *Krusz, JC, Cagle, J, submitted Headache and Pain 2006

13 metochlopramide antinauseants can be dosed IM by patient promethazine older, drowsiness, not as potent prochlorperazine older etc droperidol can be given IM by patient micro dosing compared to regular use ondansetron, granisetron, dolasetron

14 Lidocaine Indiscriminate sodium channel blocking agent Can have predictive value for oral meds (about 5-6) Needs pulse oximetry monitoring Can be done repetitively during flare-ups Go slow, go long (3-6 hours)

15 propofol Anesthetic agent used in non-anesthetic [conscious sedation] doses Short half-life Very specific pharmacology GABA A receptors No p.o. equivalent

16 ketamine Blocks NMDA-type glutamate receptors Narrow therapeutic spectrum It can break a pain cycle It can reduce opioid tolerance tried in CRPS and neuropathic pain We have the largest database for refractory migraines, cluster, HC, CPH CDH and mixed headache disorders with pain

17 tramadol Does not exist in US available in Europe non-toxic with oral agent available Can lead to direct oral treatment without titration IV doses get into CNS better; sometimes can t be mimicked by po dosing

18 levetiracetam IND pending per speaker oral agent available- with efficacy in migraine and neuropathic pain shown non-toxic, no labs efficacy in cluster headache and TN

19 IV baclofen Powerful spasticity agent Gets into CNS well Not available in US po can be tried if IV works well

20 Ze Future Botulinum toxins for specific scenarios Intramuscular administration (usual) Intradermal administration (new)* New indication for CM Other treatments being developed CGRP inhibitors (on hold) CB1, CB2 antagonists VR1 and VR2 antagonists * Krusz JC, Poster presentation: AHS 44th Annual Scientific Meeting, Seattle, WA; June 21-23, 2002.

21 It s much easier to treat headaches today! Stay Tuned

Inpatient Treatment of Refractory Headache

Inpatient Treatment of Refractory Headache Inpatient Treatment of Refractory Headache MaryAnn Mays, MD Headache Center Center for Neurological Restoration Neurological Institute Cleveland Clinic Disclosures Speakers Bureau for Allergan, Teva, and

More information

Acute Pain Management in Children an update

Acute Pain Management in Children an update Acute Pain Management in Children an update Frances W. Craig, MD FAAP East Tennessee Children s Hospital Overview Some pain basics Why we don t treat pain and why we should Non pharmacologic approaches

More information

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in Anesthesia and Neurology Harvard Medical School Limited time

More information

CHAPTER 4 PAIN AND ITS MANAGEMENT

CHAPTER 4 PAIN AND ITS MANAGEMENT CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain

More information

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines

More information

Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am

Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am Tim R Brown, PharmD, BCACP, FASHP Director of Clinical Pharmacotherapy Cleveland Clinic Akron General Center for Family

More information

Anesthesia for OutPatient Spine Surgery. Michael A. Kellams, D.O.

Anesthesia for OutPatient Spine Surgery. Michael A. Kellams, D.O. Anesthesia for OutPatient Spine Surgery Michael A. Kellams, D.O. DISCLOSURE None! Hot Topics 2017 -Multimodal Analgesia/ERAS -TAP block -Inpatient procedures outpatient (Fusions) Multimodal Analgesia -Using

More information

Ketamine for Migraine Headaches

Ketamine for Migraine Headaches Ketamine for Migraine Headaches Natalie H. Strand, MD Disclosure Nothing to disclose 1 Learning Objectives Review the diagnostic criteria for migraine Describe the clinical presentation of migraine Explain

More information

CHAPTER 4 PAIN AND ITS MANAGEMENT

CHAPTER 4 PAIN AND ITS MANAGEMENT CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain

More information

Types of epilepsy. 1)Generalized type: seizure activity involve the whole brain, it is divided into:

Types of epilepsy. 1)Generalized type: seizure activity involve the whole brain, it is divided into: Types of epilepsy We have different types of epilepsy, so it is not one type of seizures that the patient can suffer from; we can find some patients with generalized or partial seizure. So, there are two

More information

Neuro Basics SLO Practice (online) Page 1 of 5

Neuro Basics SLO Practice (online) Page 1 of 5 Neuro Basics SLO Practice (online) Page 1 of 5 1) Biogenic amines include ACh, NE, EPI and? a) Melatonin b) Dopamine c) Serotonin d) Histamine e) All of the neurotransmitters listed are biogenic amines.

More information

BOTULINUM TOXIN THERAPY FOR CERVICOGENIC HEADACHE AND NECK PAIN

BOTULINUM TOXIN THERAPY FOR CERVICOGENIC HEADACHE AND NECK PAIN BOTULINUM TOXIN THERAPY FOR CERVICOGENIC HEADACHE AND NECK PAIN Dr. Laxman Bahroo Director; Botulinum Toxin Clinic Director; Neurology Residency Program Associate Professor of Neurology Objectives Discuss

More information

Goals for sedation during mechanical ventilation

Goals for sedation during mechanical ventilation New Uses of Old Medications Gina Riggi, PharmD, BCCCP, BCPS Clinical Pharmacist Trauma ICU Jackson Memorial Hospital Disclosure I do not have anything to disclose Objectives Describe the use of ketamine

More information

Acute Postoperative Pain. David Radvinsky, MD March 24, 2016

Acute Postoperative Pain. David Radvinsky, MD March 24, 2016 Acute Postoperative Pain David Radvinsky, MD March 24, 2016 Objectives 1. Discuss the multimodal approach to pain management and discuss the various classes of drugs based on receptor mechanism. 2. Give

More information

Prevention of Antineoplastic Medication induced Nausea and Vomiting in Pediatric Cancer Patients

Prevention of Antineoplastic Medication induced Nausea and Vomiting in Pediatric Cancer Patients Prevention of Antineoplastic Medication induced Nausea and Vomiting in Pediatric Cancer Patients Done by :Meznah Zaid Al-Mutairi Pharm.D Candidate PNU University College of Pharmacy Introduction Nausea

More information

If we are going to treat this, of course it's like most things, we want to treat the underlying cause as well as the effect.

If we are going to treat this, of course it's like most things, we want to treat the underlying cause as well as the effect. Systemic Management of Nausea: Antiemetics Bruce Flint O.D. Antiemetics: This is for controlling nausea and vomiting. These are multiple conditions that's causing this. It's kind of common. I'm sure all

More information

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE IHS Classification 1989 (updated 2004) Primary Headaches 4 categories Migraine Tension-type Cluster and other trigeminal

More information

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1). Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: November 30, 2018 Migranal Nasal Spray

More information

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017 Optimizing the Acute Treatment of Migraine Brian M. Plato, DO, FAHS Norton Neuroscience Institute Louisville, KY Disclosures Speakers Bureau (personal): Allergan, Depomed, Avanir Research Funding (paid

More information

Iroquois Healthcare Association (IHA) Opioid Alternative Project. Clinician Training Materials

Iroquois Healthcare Association (IHA) Opioid Alternative Project. Clinician Training Materials Iroquois Healthcare Association (IHA) Opioid Alternative Project Clinician Training Materials Introduction IHA Opioid Alternative Project Clinician Toolkit Course Overview Thank you for participating

More information

MEDICAL POLICY SUBJECT: KETAMINE INFUSION THERAPY FOR THE TREATMENT OF CHRONIC PAIN SYNDROMES POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY SUBJECT: KETAMINE INFUSION THERAPY FOR THE TREATMENT OF CHRONIC PAIN SYNDROMES POLICY NUMBER: CATEGORY: Technology Assessment Clinical criteria used to make utilization review decisions are based on credible scientific evidence published in peer reviewed medical literature generally recognized by the medical community. Guidelines

More information

Chronic Daily Headaches

Chronic Daily Headaches Chronic Daily Headaches ANWARUL HAQ, MD, MRCP(UK), FAHS DIRECTOR BAYLOR HEADACHE CENTER, DALLAS, TEXAS DISCLOSURES: None OBJECTIVES AT THE CONCLUSION OF THIS ACTIVITY, PARTICIPANTS WILL BE ABLE TO: define

More information

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES GENERAL PRINCIPLES Neuropathic pain may be relieved in the majority of patients by multimodal management A careful history and examination are essential.

More information

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. MIGRAINE UPDATE Karen L. Bremer, MD November 16, 2018 Objectives & Disclosures Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. Disclosure: I am

More information

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders Goals One-Year Prevalence of Common Headache Disorders Impact of primary headache syndromes Non pharmacologic Rx of migraine individualized to patient triggers Complementary and alternative Rx of migraine

More information

Addressing Emergency Neuro- Pharmacologic Controversies Head-On. What dose of IV benzodiazepine makes you uncomfortable?

Addressing Emergency Neuro- Pharmacologic Controversies Head-On. What dose of IV benzodiazepine makes you uncomfortable? Addressing Emergency Neuro- Pharmacologic Controversies Head-On 38 y/o 136 bpm Bryan D. Hayes @PharmERToxGuy Sz, tremor, hallucinations Which benzodiazepine would you administer first? Why? Diazepam Lorazepam

More information

Inpatient Treatment of Status Migraine With Dihydroergotamine in Children and Adolescents

Inpatient Treatment of Status Migraine With Dihydroergotamine in Children and Adolescents Headache 2008 the Authors Journal compilation 2008 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2008.01293.x Published by Wiley Periodicals, Inc. Brief Communication Inpatient Treatment

More information

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi

GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics Dr. Alia Shatanawi 11-04-2018 Drugs used in Irritable Bowel Syndrome Idiopathic, chronic, relapsing disorder characterized by abdominal discomfort

More information

Management of Postoperative Nausea and Vomiting in Ambulatory Surgery The Big Little Problem

Management of Postoperative Nausea and Vomiting in Ambulatory Surgery The Big Little Problem Management of Postoperative Nausea and Vomiting in Ambulatory Surgery The Big Little Problem Mary Keyes, MD KEYWORDS Postoperative nausea and vomiting PONV prophylaxis PONV in ambulatory surgery KEY POINTS

More information

Isle of Wight Syringe Driver Compatibility Guidelines

Isle of Wight Syringe Driver Compatibility Guidelines Isle of Wight Syringe Driver Compatibility Guidelines Produced by The Earl Mountbatten Hospice, Isle of Wight Written January 2015, revision due January 2018 This guideline is available as a paper pocketbook

More information

MEDICAL PROTOCOL FOR ARACHNOIDITIS

MEDICAL PROTOCOL FOR ARACHNOIDITIS MEDICAL PROTOCOL FOR ARACHNOIDITIS c arachnoiditis education project METHOD OF Forest Tennant M.D., Dr. P.H. Veract Intractable Pain Clinic 338 S. Glendora Ave. West Covina, CA 91790 626-919-0064 Fax:

More information

Symptom Management. Thomas McKain, MD, ABFM, ABHPM Medical Director

Symptom Management. Thomas McKain, MD, ABFM, ABHPM Medical Director Symptom Management Nausea & Vomiting Thomas McKain, MD, ABFM, ABHPM Medical Director Mr. Jones has nausea and vomiting. May I initiate Compazine from the Comfort Pak? Objectives 1. Delineate the Differential

More information

Treatment of Headache in the ED

Treatment of Headache in the ED Treatment of Headache in the ED Benjamin W. Friedman, MD, MS, FAAEM Associate professor of Emergency Medicine Albert Einstein College of Medicine Montefiore Medical Center Disclosure Topics of Discussion

More information

Alcohol Antagonists 1

Alcohol Antagonists 1 Alcohol Antagonists 1 What is an alcohol antagonist? An alcohol antagonist is a drug that specifically blocks the effects of alcohol. If you take an alcohol antagonist and then drink a bunch of alcohol,

More information

ISSN doi: /head VC 2015 American Headache Society Published by Wiley Periodicals, Inc.

ISSN doi: /head VC 2015 American Headache Society Published by Wiley Periodicals, Inc. ISSN 0017-8748 Headache doi: 10.1111/head.12746 VC 2015 American Headache Society Published by Wiley Periodicals, Inc. Review Article Acute Treatment Therapies for Pediatric Migraine: A Qualitative Systematic

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acetaminophen in chronic pain management, 225 Acupuncture in chronic pain management, 251, 338 339 Ajurvedic medicine in chronic pain management,

More information

Measure Abbreviation: PONV 01 (MIPS 430)

Measure Abbreviation: PONV 01 (MIPS 430) Measure Abbreviation: PONV 01 (MIPS 430) *PONV 01 is built to the specification outlined by the Merit Based Incentive Program (MIPS) 430: Prevention of Post-Operative Nausea and Vomiting (PONV) Combination

More information

Building a Headache Infusion Program

Building a Headache Infusion Program Building a Headache Infusion Program Lauren Doyle Strauss, DO UCNS Board Certified Headache Specialist Headache Clinic Director Assistant Professor in Pediatric Neurology Associate Residency Director,

More information

Disclosures. Triptans for Kids 5/16/13

Disclosures. Triptans for Kids 5/16/13 5/16/13 Disclosures Triptans for Kids Amy A. Gelfand, MD GelfandA@neuropeds.ucsf.edu Departments of Neurology and Pediatrics UCSF Child Neurology and Headache Center I receive grant funding from: NIH/NINDS

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available at: ALL Adult Facilities Non Categorized SUB ED Abdominal Pain Protocol(SUB)* ***The above subphase is available at the end of the plan*** SUB ED Abdominal Pain Protocol Lab

More information

Results of a one-year, retrospective medication use evaluation. Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital

Results of a one-year, retrospective medication use evaluation. Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital Results of a one-year, retrospective medication use evaluation Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital Briefly review ketamine s history, mechanism of action, and unique properties

More information

General Anesthesia. Mohamed A. Yaseen

General Anesthesia. Mohamed A. Yaseen General Anesthesia Mohamed A. Yaseen M.S,c Surgery Before Anesthesia General Anesthesia ( GA ) Drug induced absence of perception of all sensation allowing surgery or other painful procedure to be carried

More information

BEYOND OPIOIDS: ADJUNCTS FOR TREATING PAIN

BEYOND OPIOIDS: ADJUNCTS FOR TREATING PAIN BEYOND OPIOIDS: ADJUNCTS FOR TREATING PAIN Ronald Januchowski, D.O. 2017 Objectives By the end of the presentation, the learner should be able to: Summarize the risks of opiates when used for non-cancer

More information

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment Clinical Highlights 1. Headache is diagnosed by history and physical examination with limited need for imaging or laboratory tests. 2. Warning signs of possible disorder other than primary headache are:

More information

Ergotamine/Dihydroergotamine Products

Ergotamine/Dihydroergotamine Products Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice

morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice PATIENT CONTROLLED ANALGESIA (PCA) PLAN Allergies: Medication Selection: morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice HYDROmorphone (Dilaudid ) 6 mg/ 30 ml (0.2 mg/ml) fentanyl 300 mcg/ 30 ml (10 mcg/ml)

More information

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES 1 JUSTIN A. OSSMAN, MD CHATTANOOGA FAMILY MEDICINE UPDATE OH, MY ACHING HEAD! MANAGING HEADACHE IN THE OUTPATIENT SETTING 2 I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE OBJECTIVES International

More information

DECONTAMINATION AGENTS and ANTIEMETICS *** This material won t be covered in lecture, but you are responsible for it***

DECONTAMINATION AGENTS and ANTIEMETICS *** This material won t be covered in lecture, but you are responsible for it*** Decontamination and Antiemetics Med 5724 Page 1 of 8 DECONTAMINATION AGENTS and ANTIEMETICS *** This material won t be covered in lecture, but you are responsible for it*** REFERENCES: Katzung (9th ed.)

More information

Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM Management options for Migraine Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM Assessment The Migraine Disability Assessment Score MIDAS Complete loss of work Partial loss of work Off

More information

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine Pain November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine Objectives To be able to define pain To be able to evaluate pain To be able to classify types of pain To learn appropriate

More information

Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20

Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20 1 2 3 4 5 6 Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20 years Efficacy of BoNT type A (onabotulinumtoxina,

More information

Measure Abbreviation: PONV 01 (MIPS 430)

Measure Abbreviation: PONV 01 (MIPS 430) Measure Abbreviation: PONV 01 (MIPS 430) *PONV 01 is built to the specification outlined by the Merit Based Incentive Program (MIPS) 430: Prevention of Post-Operative Nausea and Vomiting (PONV) Combination

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Intravenous Anesthetics for the Treatment of Chronic Pain File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intravenous_anesthetics_for_the_treatment_of_chronic_pain

More information

Pain and its Treatments. Our Goals: Understand: What is pain and what causes it? 2. What are different types of pain? 3. How do opioid drugs work?

Pain and its Treatments. Our Goals: Understand: What is pain and what causes it? 2. What are different types of pain? 3. How do opioid drugs work? Pain and its Treatments Cheryl Stucky, Ph.D. Medical College of Wisconsin Our Goals: Understand: 1. What is pain and what causes it? 2. What are different types of pain? 3. How do opioid drugs work? What

More information

Why Patients Experience Nausea and Vomiting and What to Do About It

Why Patients Experience Nausea and Vomiting and What to Do About It Why Patients Experience Nausea and Vomiting and What to Do About It Rebecca Clark-Snow, RN, BSN, OCN The University of Kansas Cancer Center Westwood, Kansas Multiple Roles for Supportive Care in Cancer

More information

Clinical Policy: Nabilone (Cesamet) Reference Number: ERX.NPA.35 Effective Date:

Clinical Policy: Nabilone (Cesamet) Reference Number: ERX.NPA.35 Effective Date: Clinical Policy: (Cesamet) Reference Number: ERX.NPA.35 Effective Date: 09.01.17 Last Review Date: 08.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Zonisamide for migraine prophylaxis in refractory patients

Zonisamide for migraine prophylaxis in refractory patients Thomas Jefferson University Jefferson Digital Commons Department of Neurology Faculty Papers Department of Neurology March 2006 Zonisamide for migraine prophylaxis in refractory patients Avi Ashkenazi

More information

SEEING KETAMINE IN A NEW LIGHT

SEEING KETAMINE IN A NEW LIGHT SEEING KETAMINE IN A NEW LIGHT BobbieJean Sweitzer, M.D., FACP Professor of Anesthesiology Director of Perioperative Medicine Northwestern University Bobbie.Sweitzer@northwestern.edu LEARNING OBJECTIVES

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG DRUG AND TREATMENT Available at: ALL Adult Facilities Non Categorized SUB Protocol(SUB)* SUB Protocol Lab Orders(SUB)* ED Rainbow Tubes(SUB)* ***Reminder: Order ED Rainbow Tubes (SUB) as a separate form***

More information

Skeletal Muscle Relaxants. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014

Skeletal Muscle Relaxants. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014 Skeletal Muscle Relaxants Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014 The nicotinic Acetycholine receptor Present at the neuromuscular junction, peripheral

More information

Clinical Learning Days November 10, 2017

Clinical Learning Days November 10, 2017 Migraine Clinical Learning Days November 10, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache Disclosures: none Learning Objectives: At the conclusion

More information

Refractory Status Epilepticus in Children: What are the Options?

Refractory Status Epilepticus in Children: What are the Options? Refractory Status Epilepticus in Children: What are the Options? Weng Man Lam, PharmD, BCPS, BCPPS PICU Clinical Pharmacy Specialist Memorial Hermann Texas Medical Center November 11, 2017 Objectives 1.

More information

Neuropathic Pain in Palliative Care

Neuropathic Pain in Palliative Care Neuropathic Pain in Palliative Care Neuropathic Pain in Advanced Cancer Affects 40% of patients Multiple concurrent pains are common Often complex pathophysiology with mixed components Nocioceptive Neuropathic

More information

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest. Faculty Disclosure Karen L. Bremer, MD Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest. HEADACHE UPDATE Karen L. Bremer, MD November 10, 2017 karen.bremer@creighton.edu

More information

Spinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018

Spinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018 Spinal Cord Injury Pain Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018 Objectives At the conclusion of this session, participants should be able to: 1. Understand the difference between nociceptive

More information

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS ACUTE THEAPIES TIPTANS TICYCLIC ANTIDEPESSANTS When starting acute treatment, healthcare professionals should warn patients about the risk of developing medication-overuse headache. ASPIIN Aspirin (900

More information

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: June 22, 2017 Migranal Nasal Spray

More information

Introduction. 1 person in 20 will have an epileptic seizure at some time in their life

Introduction. 1 person in 20 will have an epileptic seizure at some time in their life Introduction 1 person in 20 will have an epileptic seizure at some time in their life Epilepsy is diagnosed on the basis of two or more epileptic seizures. Around 450,000 people in the UK have epilepsy

More information

Gastrointestinal and urinary complications in the postoperative period

Gastrointestinal and urinary complications in the postoperative period The 13 th Annual Perioperative Medicine Summit Fort Lauderdale, Florida Gastrointestinal and urinary complications in the postoperative period Dan Hunt, MD Professor of Medicine Director, Division of Hospital

More information

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine Acute Treatment Strategies in Adult & Pediatric Patients Theresa Mallick Searle, MS, RN BC, ANP BC Disclosures Speakers Bureau: Allergan, Depomed Acute Treatment Strategies in Adult & Pediatric Patients

More information

How do we treat migraine? New SIGN Guidelines

How do we treat migraine? New SIGN Guidelines How do we treat migraine? New SIGN Guidelines Managing your migraine Migraine Trust, Edinburgh 2018 Callum Duncan Consultant Neurologist Aberdeen Royal Infirmary Chair SIGN Guideline 155 Premonitory Mood

More information

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine MEDICAL CANNABIS FOR NEUROLOGICAL DISEASES July 15 TH, 2017 ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine GOALS AND OBJECTIVES

More information

PAIN PODCAST SHOW NOTES:

PAIN PODCAST SHOW NOTES: PAIN PODCAST SHOW NOTES: Dallas Holladay, DO Ultrasound Fellow Cook County Hospital Rush University Medical Center Jonathan D. Alterie, DO PGY-2, Emergency Medicine Midwestern University An overview of

More information

Choose a category. You will be given the answer. You must give the correct question. Click to begin.

Choose a category. You will be given the answer. You must give the correct question. Click to begin. Instructions for using this template. Remember this is Jeopardy, so where I have written Answer this is the prompt the students will see, and where I have Question should be the student s response. To

More information

Refractory Central Neurogenic Pain in Spinal Cord Injury. Case Presentation

Refractory Central Neurogenic Pain in Spinal Cord Injury. Case Presentation Refractory Central Neurogenic Pain in Spinal Cord Injury Case Presentation Edwin B. George, MD, PhD Wayne State University John D. Dingell VAMC 2012 Disclosures This continuing education activity is managed

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

What A Headache! Theresa Biesiada March 8, 2012

What A Headache! Theresa Biesiada March 8, 2012 What A Headache! Theresa Biesiada March 8, 2012 Objectives Describe the EM relevance of headaches and migraines Discuss the rationale for steroid therapy Review the evidence Conclusions My inspiration

More information

NEUROBIOLOGY ALCOHOLISM

NEUROBIOLOGY ALCOHOLISM NEUROBIOLOGY ALCOHOLISM THERE HAS BEEN A MAJOR THEORETICAL SHIFT IN MEDICATION DEVELOPMENT IN ALCOHOLISM Driven by animal models of intermittent ethanol administration followed by termination, then access

More information

Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents

Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents Myth or Reality? Complete Recovery means a medication-free state True or False? Treatment of Alcoholism Assessment Motivation Alcohol

More information

REFERENCE CODE GDHC378DFR PUBLICAT ION DATE M ARCH 2014 BOTOX (MIGRAINE) - FORECAST AND MARKET ANALYSIS TO 2023

REFERENCE CODE GDHC378DFR PUBLICAT ION DATE M ARCH 2014 BOTOX (MIGRAINE) - FORECAST AND MARKET ANALYSIS TO 2023 REFERENCE CODE GDHC378DFR PUBLICAT ION DATE M ARCH 2014 BOTOX (MIGRAINE) - Executive Summary Botox: Key Metrics in the 7MM* for Migraine, 2012-2023 2012 Market Sales US $434.3m 5 EU $68.3m Japan Total

More information

Nausea and Vomiting in Palliative Care

Nausea and Vomiting in Palliative Care Nausea and Vomiting in Palliative Care Definitions Nausea - an unpleasant feeling of the need to vomit Vomiting - the expulsion of gastric contents through the mouth, caused by forceful and sustained contraction

More information

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Acute pain management in opioid tolerant patients. Muhammad Laklouk Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)

More information

Opioid Free Anesthesia

Opioid Free Anesthesia Opioid Free Anesthesia Michael H Wilhelm, CRNA, APRN Opioid Free Anesthesia Michael H Wilhelm, CRNA, APRN 1 Why is pain important? Primary contributor to post-operative distress 56% of patients state that

More information

Nervous System Communication. Nervous System Communication. The First Nerve Cells 1/2/11

Nervous System Communication. Nervous System Communication. The First Nerve Cells 1/2/11 Nervous System Communication Nervous System Communication Process information Transfer information to other neurons Generate behavior and experience The First Nerve Cells Developed in primitive animals

More information

Nausea. Assessment & Management. R J Crossno, MD, CMD, FAAFP, FAAHPM. Disclosures

Nausea. Assessment & Management. R J Crossno, MD, CMD, FAAFP, FAAHPM. Disclosures Nausea Assessment & Management R J Crossno, MD, CMD, FAAFP, FAAHPM Disclosures Dr. Crossno discloses his employment as Area Medical Director for VistaCare VistaCare has provided commercial support for

More information

Fundamentals of Psychopharmacology. Distribution of Receptors Influences Safety

Fundamentals of Psychopharmacology. Distribution of Receptors Influences Safety Fundamentals of Psychopharmacology Matt Schalles UCSD Cognitive Science mdschalles@ucsd.edu Distribution of Receptors Influences Safety Opioid Receptors Cannabinoid Receptors 1 Brief History of Drug Advances

More information

Chronic daily headache (CDH) is a relatively

Chronic daily headache (CDH) is a relatively CHRONIC HEADACHE: TODAY AND INTO THE FUTURE * Nabih M. Ramadan, MD ABSTRACT Chronic daily headache (CDH) is the phenotypic manifestation of diverse conditions with varied etiologies and sometimes divergent

More information

Arrhythmias. Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium.

Arrhythmias. Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium. Arrhythmias Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium. However, in clinic it present as a complex family of disorders that show variety of symptoms, for

More information

1. On how many days in the last 3 months did you miss work or school because of your headaches?

1. On how many days in the last 3 months did you miss work or school because of your headaches? The Migraine Disability Assessment Test The MIDAS (Migraine Disability Assessment) questionnaire was put together to help you measure the impact your headaches have on your life. The information on this

More information

A. Incorrect! Seizures are not typically linked to alcohol use. B. Incorrect! Epilepsy is a seizure that is commonly associated with convulsions.

A. Incorrect! Seizures are not typically linked to alcohol use. B. Incorrect! Epilepsy is a seizure that is commonly associated with convulsions. Pharmacology - Problem Drill 17: Central Nervous System Depressants Question No. 1 of 10 Instructions: (1) Read the problem statement and answer choices carefully (2) Work the problems on paper as 1. occur(s)

More information

10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD

10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD } Depomed Consultant 2014 to present } Avanir Consultant 2014 to present } Amgen

More information

SOMA PILLS SIDE EFFECTS

SOMA PILLS SIDE EFFECTS SOMA PILLS SIDE EFFECTS Soma Pills Side Effects Soma compound carisoprodol 350 mg Do soma make you lose weight fast Soma drug donepezil hcl 10mg tablet review Soma compound and blood donation O que significa

More information

Sedative-Hypnotics. Sedative Agents (General Considerations)

Sedative-Hypnotics. Sedative Agents (General Considerations) Sedative Agents (General Considerations) No best sedative agent Any agent given in sufficient dosage can produce any level of sedation Intravenous dosing is more predictable then intramuscular or oral

More information

Inpatient Management of Trauma Related Pain

Inpatient Management of Trauma Related Pain Inpatient Management of Trauma Related Pain STOMP Summit September 9, 2016 Ann O Rourke, MD, MPH University of Wisconsin Department of Surgery 1 Our patient Small SDH Intubated Hemopneumothorax with multiple

More information

Innovative Pain Management Practices in Spine Surgery Patients

Innovative Pain Management Practices in Spine Surgery Patients Disclosures Innovative Pain Management Practices in Spine Surgery Patients There are no conflicts of interest or relevant financial interests in making this presentation. Matt Kresl PharmD, BCPS Pharmacist

More information

Pain Assessment. William Bush VMD, DACVIM (Neurology)

Pain Assessment. William Bush VMD, DACVIM (Neurology) Pain Assessment William Bush VMD, DACVIM (Neurology) bbush@bvns.net Copper 11, FS, Mixed Breed Copper Video Presents for lameness, muscle atrophy, slow to rise and one owner is concerned about pain On

More information

Pain Management Strategies Webinar/Teleconference

Pain Management Strategies Webinar/Teleconference Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits

More information

EPIDURAL / INTRATHECAL POST-OP PLAN

EPIDURAL / INTRATHECAL POST-OP PLAN EPIDURAL / INTRATHECAL POST-OP PLAN Diagnosis Weight PHYSICIAN S Allergies Patient Care Vital Signs Per Unit Standards, PLUS check and record RR q1h x 12, then q2h x 6, until 24h following narcotic administration.

More information

Nerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS

Nerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS Nerve Blocks & Long Acting Analgesia for Plastic Surgeons Karol A Gutowski, MD, FACS Disclosures None related to this topic Why is Non-Opioid Analgesia Important Opioid epidemic Less opioid use Less PONV

More information

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG Available at ALL facilities Non Categorized SUB ED Chest Pain: STEMI Protocol(SUB)* SUB ED Chest Pain: STEMI Protocol Lab Orders(SUB)* ED Rainbow Tubes(SUB)* ***Reminder: Order ED Rainbow Tubes (SUB) as

More information